Skip to main content
. 2019 May 20;10(3):147–152.

Table II.

Characteristics of patients with adenomyosis malignant transformation

Adenomyosis without malignant transformation (N=57) Adenomyosis with malignant transformation (N=7) P-value
Age (years) 63 ± 9.3 65 ± 10.1 0.60
Menopause 49 (86%) 7 (100%) 0.58
Co-existing Fibroids 24 (42.1%) 1 (14.3%) 0.23
Co-existing Endometriosis 1 (1.8%) 1 (14.3%) 0.20
CA125 elevated (>35 U/ml) 8 (17.8%) 2 (33.3%) 0.58
FIGO Stage 0.57
I 51 (89.5%) 6 (85.7%)
II 3 (5.3%) 0 (0%)
III 2 (3.5%) 1 (14.3%)
IV 1 (1.7%) 0 (0%)
Tumor Grade 0.19
1 20 (35.1%) 2 (28.6%)
2 33 (57.9%) 3 (42.8%)
3 4 (7%) 2 (28.6%)